The global microfluidics market size is expected to reach USD 55.18 billion by 2028 according to a new study by Polaris Market Research. The report “Microfluidics Market Share, Size, Trends, Industry Analysis Report, By Material (Silicon, Glass, Polymer, PDMS); Technology (Medical, Non-medical); By Application; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The major factors driving the growth of the market are the need for miniaturization of PoC devices and the need to develop new 3D culture models that can mimic the pathophysiology of human organs for disease models and drug screening.
The use of the product will greatly enhance PoC devices in speed and accuracy. The increased incidences of chronic diseases such as diabetes led to the increased use of PoC devices as these devices can help monitor the disease in a home setup.
New culture models such as Organ-on-a-chip model systems are developed using microfluidic technology. These systems can mimic the physiology of organs such as lungs, kidneys, and others. They have applications in disease modeling to understand the pathophysiology of the disease and in drug screening as currently available in vitro platforms for drug screening have limitations.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/microfluidics-market/request-for-sample
In 2021, LumiraDx received approval for a microfluidic immunofluorescence assay to detect SARS-CoV-2 antigen in Japan and Brazil. In January 2021, LexaGene announced the launch of the MiQLab system from research-only use to POC use to detect the SARS-CoV-2 virus after receiving emergency use authorization (EUA) in the U.S.
COVID-19 pandemic is expected to further fuel the growth of the global industry. There is a time-bound urgency to develop rapid diagnostic tests and screen and develop drugs in pandemic times to bring down the pandemic under control. The product-based PCR will help significantly in the diagnosis of disease.
Market Participants such as Roche Ltd, PerkinElmer, Agilent Technologies, Inc., Danaher Corporation, Abbott Laboratories, Life Technologies Corporation, Thermo Fisher Scientific, Biomerieu, Illumina, Inc., Qiagen, Bio-Rad Laboratories, Elveflow, Micronit Micro Technologies B.V., Cellix Ltd., and Fluidigm Corporation are few key players operating in the global industry.
Polaris Market Research has segmented the microfluidics market report on the basis of technology, material, application, and region:
Microfluidics, Technology Outlook (Revenue – USD Million, 2016 – 2028)
- PCR & RT-PCR
- Gel Electrophoresis
- Enzyme-linked Immunosorbent Assay (ELISA)
Microfluidics, Material Outlook (Revenue – USD Million, 2016 – 2028)
- Polydimethylsiloxane (PDMS)
Microfluidics, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Continuous Flow Microfluidic
- Optofluidics and Microfluidic
- Acoustofluidics and Microfluidics
- Electrophoresis and Microfluidics
Microfluidics, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa